Lineage Cell Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 05/15/2026 | 49.56 M | $78.31 M | 0.00% | 21.54% |
| 05/15/2026 | 8.32 M | $13.14 M | 100.00% | 3.62% | |
| DEFENDER CAPITAL, LLC. | 04/13/2026 | 6.73 M | $10.63 M | -1.46% | 2.92% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 5.56 M | $8.79 M | 163.52% | 2.42% |
| RAFFLES ASSOCIATES LP | 05/15/2026 | 5.36 M | $8.47 M | 0.00% | 2.33% |
| FIFTH THIRD BANCORP | 05/01/2026 | 4.60 M | $7.27 M | 100.00% | 2.00% |
| BLACKROCK, INC. | 05/13/2026 | 3.86 M | $6.11 M | 0.80% | 1.68% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 3.18 M | $5.03 M | 100.00% | 1.38% |
| MARSHALL WACE, LLP | 05/15/2026 | 3.07 M | $4.84 M | 125.03% | 1.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.52 M | $3.99 M | 2.52% | 1.10% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 2.13 M | $3.36 M | -11.63% | 0.92% |
| MORGAN STANLEY | 05/15/2026 | 1.87 M | $2.95 M | -6.51% | 0.81% |
| UBS GROUP AG | 05/05/2026 | 1.37 M | $2.17 M | 648.37% | 0.60% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 1.32 M | $2.09 M | 100.00% | 0.58% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 1.30 M | $2.06 M | 84.69% | 0.57% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.17 M | $1.85 M | -18.72% | 0.51% |
| STATE STREET CORP | 05/15/2026 | 1.09 M | $1.72 M | 7.27% | 0.47% |
| JANE STREET GROUP, LLC | 05/12/2026 | 993.21 K | $1.57 M | -1.15% | 0.43% |
| RED CRANE WEALTH MANAGEMENT, LLC | 04/29/2026 | 597.26 K | $943.68 K | 0.00% | 0.26% |
| NORTHERN TRUST CORP | 05/14/2026 | 499.13 K | $788.62 K | 4.14% | 0.22% |
| SEI INVESTMENTS CO | 05/13/2026 | 422.27 K | $667.20 K | 56.80% | 0.18% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 419.36 K | $662.58 K | 111.96% | 0.18% |
| BARCLAYS PLC | 05/15/2026 | 393.31 K | $621.43 K | 12.85% | 0.17% |
| EAM INVESTORS, LLC | 05/13/2026 | 346.62 K | $547.65 K | -21.62% | 0.15% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 304.36 K | $480.89 K | 90.93% | 0.13% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 259.56 K | $410.11 K | 22.81% | 0.11% |
| HRT FINANCIAL LP | 05/14/2026 | 232.26 K | $366.00 K | 100.00% | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 221.00 K | $349.18 K | 0.00% | 0.10% |
| 04/23/2026 | 216.00 K | $341.28 K | 0.00% | 0.09% | |
| FMR LLC | 05/15/2026 | 193.31 K | $305.43 K | 0.70% | 0.08% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 05/15/2026 | 186.79 K | $295.14 K | 100.00% | 0.08% |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 185.06 K | $292.00 K | -44.09% | 0.08% |
| CITIGROUP INC | 05/11/2026 | 175.08 K | $276.62 K | 147.50% | 0.08% |
| CATALYST FUNDS MANAGEMENT PTY LTD | 05/11/2026 | 170.30 K | $269.07 K | 172.92% | 0.07% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 143.19 K | $226.24 K | 119.92% | 0.06% |
| CITADEL ADVISORS LLC | 05/15/2026 | 130.95 K | $206.90 K | -74.17% | 0.06% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 129.92 K | $205.28 K | 0.01% | 0.06% |
| JAIN GLOBAL LLC | 05/15/2026 | 122.05 K | $192.84 K | 214.15% | 0.05% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 111.29 K | $175.83 K | 49.48% | 0.05% |
| OMERS ADMINISTRATION CORP | 05/15/2026 | 109.00 K | $172.22 K | -61.51% | 0.05% |
| COMMONWEALTH EQUITY SERVICES, LLC | 04/27/2026 | 102.83 K | $162.47 K | -1.38% | 0.04% |
| WILLIAMS JONES WEALTH MANAGEMENT, LLC. | 05/05/2026 | 101.30 K | $160.05 K | 0.00% | 0.04% |
| HIGHTOWER ADVISORS, LLC | 05/05/2026 | 99.87 K | $157.80 K | 1.52% | 0.04% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 88.59 K | $139.96 K | -66.65% | 0.04% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 85.80 K | $135.56 K | 100.00% | 0.04% |
| VOLEON CAPITAL MANAGEMENT LP | 05/15/2026 | 85.74 K | $135.47 K | 20.81% | 0.04% |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 83.98 K | $132.70 K | 4.74% | 0.04% |
| TRUST CO OF TOLEDO NA /OH/ | 04/15/2026 | 83.80 K | $132.40 K | 147.95% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 79.80 K | $126.08 K | 56.16% | 0.03% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 63.81 K | $101.00 K | 100.00% | 0.03% |
Lineage Cell Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 170 institutional investors and hedge funds held shares of Lineage Cell Therapeutics Inc. The most heavily invested institutionals were:
BROADWOOD CAPITAL INC: 49.56 M
Defender Capital, LLC.: 6.73 M
MILLENNIUM MANAGEMENT LLC: 5.56 M
RAFFLES ASSOCIATES LP: 5.36 M
FIFTH THIRD BANCORP: 4.6 M
BlackRock, Inc.: 3.86 M
48.54% of Lineage Cell Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 128.10 M shares in the last 24 months. This purchase volume represents approximately $225.45 M in transactions.